Literature DB >> 1206760

Mchanisms of antitumor action of Corynebacterium parvum: nonspecific tumor cell destruction at site of immunologically mediated sensitivity reaction to C. parvum.

R L Tuttle, R J North.   

Abstract

Mice immunized in the footpad with Corynebacterium parvum developed a systemic mechanism with a potential for destroying syngeneic tumor cells. The development of this mechanism of antitumor action depended on the generation of a state of systemic sensitivity to C. parvum antigens, which allowed an immunologically mediated inflammatory response to be focused at the site of a tumor cell challenge or in the bed of an established tumor. This resulted in complete inhibition of growth of the former regression of the latter. This nonspecific mechanism of tumor cell destruction could be utilized only during a relatively short period when mice were responding maximally to the organism. This corresponded to a period during which there was maximum cell division in the lymph node draining the site of immunization with C. parvum, maximum systemic macrophage activation, and maximum sensitivity to eliciting injections of the organism. The potential for destroying tumor cells could be transferred to normal recipients with lymph node cells from C. parvum-immunized donors, which indicated the distinct possibility that antitumor action was based on the cell-mediated response to C. parvum antigens. That the destruction of tumor cells at the site of a C. parvum sensitivity reaction was associated with a massive influx of mono-nuclear cells provided further support for this possibility.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1206760     DOI: 10.1093/jnci/55.6.1403

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  19 in total

1.  Antibody to Corynebacterium parvum in normal human and animal sera.

Authors:  G Wolberg; G S Duncan; C Adlam; J K Whisnant
Journal:  Infect Immun       Date:  1977-03       Impact factor: 3.441

2.  An adhesive glycoprotein from rat ascites hepatoma cells potentiates natural cytotoxic activity by rat spleen cells.

Authors:  J Y Chen; R Kurano; M Hirashima; H Hayashi
Journal:  Immunology       Date:  1986-05       Impact factor: 7.397

3.  Immunological function of adhesive glycoprotein from rat ascites hepatoma cells: production of macrophage chemotactic lymphokine.

Authors:  M Hifumi; H Hayashi
Journal:  Immunology       Date:  1983-06       Impact factor: 7.397

4.  Experimental intraocular malignancy: the effect of intracameral perfusion.

Authors:  V G Wong; W R Green; Y P Liu; E R Marsden
Journal:  Trans Am Ophthalmol Soc       Date:  1979

5.  Macrophages and resistance to tumours. I. Inhibition of delayed-type hypersensitivity reactions by tumour cells and by soluble prducts affecting macrophages.

Authors:  M Nelson; D S Nelson
Journal:  Immunology       Date:  1978-02       Impact factor: 7.397

6.  Mechanisms of anti-tumor action of Corynebacterium parvum. I. Potentiated tumor-specific immunity and its therapeutic limitations.

Authors:  E S Dye; R J North; C D Mills
Journal:  J Exp Med       Date:  1981-09-01       Impact factor: 14.307

7.  Mechanisms of immunity to leishmaniasis III. The development and decay of resistance during metastatic disease.

Authors:  L W Poulter; M T Pearce
Journal:  Clin Exp Immunol       Date:  1980-11       Impact factor: 4.330

8.  Immune reaction of tumor-bearing mice to Propionibacterium acnes and the antitumor effect of the bacteria.

Authors:  V Silobrcic; G Fredrickson; R Sedlacek; H D Suit; G Wolberg
Journal:  Cancer Immunol Immunother       Date:  1982       Impact factor: 6.968

9.  Canine migration inhibitory factor: effect of Corynebacterium parvum administration.

Authors:  M S Pineiro; C A Bowles; E C Cutchins; M I Bull
Journal:  Infect Immun       Date:  1977-10       Impact factor: 3.441

10.  Development of delayed-type hypersensitivity during Mycobacterium lepraemurium infection in mice.

Authors:  L W Poulter; M J Lefford
Journal:  Infect Immun       Date:  1977-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.